UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000000507 |
|---|---|
| Receipt number | R000000615 |
| Scientific Title | Utility of real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in diagnosis of sarcoidosis; comparison with transbronchial lung biopsy (TBLB) |
| Date of disclosure of the study information | 2006/11/01 |
| Last modified on | 2013/01/02 06:38:57 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Utility of real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in diagnosis of sarcoidosis; comparison with transbronchial lung biopsy (TBLB)
Acronym
EBUS-TBNA in the diagnosis of sarcoidosis
Scientific Title
Utility of real-time endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in diagnosis of sarcoidosis; comparison with transbronchial lung biopsy (TBLB)
Scientific Title:Acronym
EBUS-TBNA in the diagnosis of sarcoidosis
Region
| Japan |
Condition
Condition
Sarcoidosis
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare the diagnostic utility of EBUS-TBNA and TBLB in patients with suspected stage I/II sarcoidosis
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Phase III
Assessment
Primary outcomes
Sensitivity of pathological diagnosis of sarcoidosis
Key secondary outcomes
Frequency of adverse effects
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Patients with suspected stage I/II sarcoidosis based on clinicoradiological pictures who need to undergo diagnostic bronchoscopy 2. Hilar-mediastinal nodes 10 mm or greater in short-axis diameter on chest computed tomography 3. 20 years and above 4. Informed consent
Key exclusion criteria
1. Serious concomitant medical illness 2. Obvious bleeding tendency 3. Pregnancy 4. Other clinical difficulties in this study
Target sample size
45
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Masahide Oki |
Organization
Nagoya Medical Center
Division name
Department of Respiratory Medicine
Zip code
Address
4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan
TEL
052-951-1111
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Masahide Oki |
Organization
Nagoya Medical Center
Division name
Department of Respiratory Medicine
Zip code
Address
4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan
TEL
052-951-1111
Homepage URL
Masahideo@aol.com
Sponsor or person
Institute
Nagoya Medical Center
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2006 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
http://jtcs.ctsnetjournals.org/cgi/content/abstract/143/6/1324
Number of participants that the trial has enrolled
Results
Of the 62 patients enrolled, 54 were given a final diagnosis of sarcoidosis. The diagnostic yield of EBUS-TBNA and TBLB for sarcoidois by showing noncaseating epithelioid cell granuloma was 94% (stage I, 97%; stage II, 88%) and 37% (stage I, 31%; stage II, 50%), respectively. The difference was statistically significant (p<0.001). One pneumothorax and 3 moderate bleeding cases (7%) resulted from TBLB, and 1 severe cough case (2%) from EBUS-TBNA.
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2006 | Year | 04 | Month | 26 | Day |
Date of IRB
Anticipated trial start date
| 2006 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2009 | Year | 03 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The sensitivity of EBUS-TBNA and TBLB for pathological diagnosis of sarcoidosis is to be observed.
Management information
Registered date
| 2006 | Year | 10 | Month | 30 | Day |
Last modified on
| 2013 | Year | 01 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000615
